-- 根據週一提交給澳洲證券交易所的文件顯示,Island Pharmaceuticals(ASX:ILA)與美國陸軍傳染病醫學研究所(USAMRIID)和德州生物醫學研究所的合作進展順利,其候選藥物Galidesivir的下一階段臨床開發預計很快就會啟動。 該公司根據澳洲政府2025財年的研發稅收優惠政策,獲得了約14.3萬澳元的退稅。此退稅與ISLA-101的持續開發相關的合格支出有關。 今年3月季度,該公司與Todd Strategy Group和MC2合作,推進了在美國的產業合作計畫。 文件補充道,Galidesivir是一種處於臨床階段的抗病毒分子,對包括伊波拉病毒、馬堡病毒、中東呼吸道症候群病毒、茲卡病毒和黃熱病病毒在內的20多種RNA病毒具有廣譜活性。 該公司股價在周一的交易中上漲了1%。
Related Articles
Ifo: German Export Morale Inches Up in April
German exporters turned slightly optimistic in April, while the overall sector moved neither forward nor backward due to geopolitical uncertainty, the ifo Institute said Monday.The ifo export expectations indicator increased to 0.1 point in April, from -0.7 points in March, as positive expectations roughly offset negative ones.Across the board, the export outlook for the automotive industry, electronics sector, and furniture manufacturers declined but remained generally positive. Expectations for shipments of food and beverages increased "significantly," while energy-intensive businesses forecasted lower exports.
Big Banc Split to Complete Class A Share Split
Big Banc Split (BNK.TO) intends to complete a stock split of its Class A shares, citing strong performance of the shares, the fund said late on Friday.Class A shareholders of record at the close of business on May 1 will receive 20 additional Class A shares for every 100 Class A shares held.At completion of the share split, the Class A shares are expected to begin trading on an ex-split basis at the opening of trading on May 4.The preferred shares of the fund will not be affected and are expected to have downside protection from a decline in the value of the fund's portfolio of about 60%.Class A unitholders will continue to receive regular monthly non-cumulative cash distributions initially in the amount of $0.12 per Class A share, or $1.44 per year, following the Share Split. As a result, the total dollar amount of distributions to be paid to the holders of Class A shares is expected to increase by about 20%.The share split is subject to the approval of the Toronto Stock Exchange.